Engineered T cells turn cancer’s strength against itself
Researchers mix gene editing with the principles of martial arts to boost T cell therapies.
gene editing
With a boost from beta, alpha thalassemia gene therapies blossom
Currently, the only cure for alpha thalassemia is a bone marrow transplant, but the success of gene therapies for related conditions points to a potential new cure.
Editing the cell’s transcripts
For cases where gene editing simply won’t work, biochemist Aseem Ansari is working on a new idea: changing how cells regulate genes.
Gene editing: DNA versus RNA
Researchers correcting the genetic causes of disease at the DNA or RNA level make their cases.
Gene edited tomatoes get a boost of vitamin D
Increasing the levels of vitamin D in tomatoes may reduce risks for cancer, neurocognitive decline, and mortality from any cause.
Behind the Scenes: Manufacturing Viruses for Hemophilia Gene Therapy
On a quest to bring new a new hemophilia gene therapy to the clinic, one research team leapt over hurdle after hurdle to produce enough viral therapeutics to treat a large number of patients.
New RNA-editing tools expand therapeutic toolkits
Improved chemistry may make RNA editing therapies more feasible in humans.
CRISPR for Vaccine Development
Discover a novel approach to vaccine discovery using CRISPR engineering.
Multiple mutations may no longer stump gene therapies
Creative solutions may enable gene therapy for more common diseases.
On the road to treating mitochondrial disease
Recent advancements in mitochondrial genome editing technologies take scientists one step closer to developing viable treatments for mitochondrial diseases, which affect 1 in 4300 adults.
